Author(s): Thaikadan Soorya Sukumaran, M. P. Venkatesh

Email(s): venkateshmpv@jssuni.edu.in

DOI: 10.5958/0974-360X.2020.00460.6   

Address: Thaikadan Soorya Sukumaran, M. P. Venkatesh
Pharmaceutical Regulatory Affairs Group, Dept. of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru-570015, Karnataka, India.
*Corresponding Author

Published In:   Volume - 13,      Issue - 6,     Year - 2020


ABSTRACT:
Post approval changes are a vital part of the pharmaceutical product life cycle management. These chemistry, manufacturing and controls (CMC) changes are done due to the changing needs, new findings and for continuous improvement. These changes need to be carefully monitored and must follow a proper regulatory path for implementation. In case of any failure to comply with regulatory requirements for post-approval CMC changes the product will be termed as misbranded or adulterated. Some of the changes may be significant and require a substantial amount of stability data and for the changes which are minor, require only a stability commitment. The change control procedures give the detail on how the changes are evaluated and implemented and how these changes will impact the stability of the product and also information on the necessary data required to support the change.


Cite this article:
Thaikadan Soorya Sukumaran, M. P. Venkatesh. Regulatory requirements for Post approval changes in Japan, Canada and Malaysia. Research J. Pharm. and Tech 2020; 13(6):2585-2590. doi: 10.5958/0974-360X.2020.00460.6


REFERENCES:
1.    Post-Approval Change Management Systems in the ICH Region with Focus on “Established Conditions” Available from: https://dgra.de/media/pdf/studium/masterthesis/master_wiechmann_anja_2017.pdf
2.    Amsa P, Pandey GK, Bhowmick M. The Scope of Web-based Clinical Research in Pharmacy. Research J. Pharm. and Tech. 2008;1(3):121-123.
3.    Amitava Roy, Amitava Ghosh. The Sixth International Conference on Harmonisation (ICH 6) – A Promising Future in Global Pharmaceutical Industry. Research J. Pharm. and Tech. 2008; 1(3):161-165.
4.    Patel Dhaval V, Patel Biraju D. Quality Improvement Methodologies in Pharmaceutical Manufacturing. Asian J. Management. 2010; 1(1): 1-3.
5.    Post-Approval Change Regulations in Japan. Available from:  https://c.ymcdn.com/sites/casss.site-ym.com/resource/resmgr/CMC_Japan_Speaker_Slides/2013_CMCJP_HondaFutaba.pdf.
6.    Durai Anand Kumar, V. Balakrishnan. A study on ISO 9001 Quality Management System Certification – Reasons behind the failure of ISO certified Organizations. Asian J. Management. 2011; 2(4): 191-196.
7.    Swati Rawat, Akhilesh Gupta, Regulatory Requirements for Drug Development and Approval in United States: A Review. Asian J. Pharm. Res. 2011;1(1):1-6.
8.    S. S. Shuka, Bina Gidwani, Importance of Pharmacovigilance in Indian Pharmaceutical Industry. Asian J. Res. Pharm. Sci. 2012; 2(1): 4-8.
9.    Raghava Ramesh Narayana, KP Shivalinge Gowda. ICH Guidelines with Special Emphasis on Good Clinical Practice Guidelines (GCP). Research J. Pharmacology and Pharmacodynamics. 2010; 2(1):27-32.
10.    Health Canada is pleased to announce the release of the revised Post-Notice of Compliance (NOC) Changes - Quality Guidance. Available from: http://stg3plus.bpfk.gov.my/front-end/attachment/624/pharma/ 170526/170526_20160929_153425_.pdf (Assessed on: 21st June 2018)
11.    Pratik Dash, Satyajit Behera. Investigational New Drug Application Process (IND) - As a Tool for Drug Discovery. Research J. Pharm. and Tech.  2010; 2(3): 47-50
12.    Post- Notice of Compliance (NOC) Changes: Quality Document. Available from:  https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/post-notice-compliance-changes/quality-document.html (Assessed on: 24th June 2018)
13.    Hiren M. Marvaniya, Divyesh J. Vanparia, Renu Chauhan, Dhrubo Jyoti Sen. Process Analytical Technology (PAT): An Initiative Objective for Pharmaceutical C-GMP for the 21st Century. Research J. Science and Tech. 2010; 2(6): 129-133.
14.    Md. Yaqub Khan, Poonam Gupta. A Review on Marketing of OTC Drugs. Asian J. Res. Pharm.Sci. 2013; 3(2):72-78.
15.    Post- Notice of Compliance (NOC) Changes: Safety and Efficacy Document. Available from:  https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/post-notice-compliance-changes/safety-efficacy-document.html
16.   Malaysian Variation guideline for pharmaceutical products. Available from: https://www.npra.gov.my/images/Circulars_Directive/ Regulatory_Information/page-7/Malaysia-Variation-Guideline-for-Pharmaceutical-Products-2013_edition-1April2013-080513.pdf

Recomonded Articles:

Author(s): Niharika, Navneet Verma

DOI: 10.5958/0974-360X.2016.00182.7         Access: Open Access Read More

Author(s): Ravindranath S. Misal, Vishawas R. Potphode, Vijay R. Mahajan

DOI: 10.5958/0974-360X.2017.00218.9         Access: Open Access Read More

Author(s): U.S Mahadeva Rao, Khamsah Suryati Mohd, Abdurrazaq Muhammad, Bashir Ado Ahmad, Mohaslinda Mohamad, Rosmawati Mat Ali

DOI: Not Available         Access: Open Access Read More

Author(s): Archana Kushwaha, Jayanti Jaiswal, Priya Singh, Neha Rathore, Jai Prakash Dhruw, Ishu Sahu, Chhaya Singh, Krinsha Kumar Sahu, Mukta Agrawal, D. K. Tripathi, Ajazuddin, Amit Alexander

DOI: 10.5958/0974-360X.2017.00270.0         Access: Open Access Read More

Author(s): Rekha Kallam, Padma Sree K, Srinivas Arutla, MA Bari

DOI: Not Available         Access: Open Access Read More

Author(s): Homendra Kumar Sahu, Kamdev Sen, Raju Patel, Hulash Sahu, Deepika Sahu, Gulshan Sahu, Chandrashekhar Jain, Narayan Prasad Chandra, Mukta Agrawal, D. K. Tripathi, Ajazuddin, Amit Alexander

DOI: 10.5958/0974-360X.2017.00173.1         Access: Open Access Read More

Author(s): Narendra Chotai, Vishnu Patel, Harsha Patel, Uren Patel, Rajendra Kotadiya

DOI:         Access: Open Access Read More

Author(s): Vikram Kumar Sahu, Amit Mishra, Nitin Sharma, Pratap Kumar Sahu, Shubhini A. Saraf

DOI: 10.5958/0974-360X.2017.00048.8         Access: Open Access Read More

Author(s): Rao Rekha, Goswami Anju, Shekhar Shishant, Mahant Sheefali, Nanda Sanju

DOI: Not Available         Access: Open Access Read More

Author(s): Hitesh Jain, Rushi Panchal, Dilrose Pabla, Jaimini Patel, Mansi Khirwadkar

DOI: Not Available         Access: Open Access Read More

Author(s): Oruganti Sai Koushik, V. Himaja, P. Srinivasa Babu, Ramadoss Karthikeyan

DOI: 10.5958/0974-360X.2015.00298.X         Access: Open Access Read More

Author(s): H.B. Pagar, U.P. Shinde, Y.S. Agrawal, S.D. Barhate, T.S. Luhade, R.O. Sonawane

DOI: Not Available         Access: Open Access Read More

Author(s): Surya Prakash BN Gupta, Neeraj Upmanyu, Gopal Garg

DOI: Not Available         Access: Open Access Read More

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags